QUEEN AJIERE: Open Payments
NPI 1730890898 · FRANKFORT, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,449 in 57 payments from 15 companies in 2025. Trend: 2023 $2,381 · 2024 $1,275 · 2025 $1,449
Food & beverage: $1,449
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $437 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $224 |
| Janssen Pharmaceuticals, Inc | 4 | $115 |
| Alkermes, Inc. | 4 | $98 |
| E.R. Squibb & Sons, L.L.C. | 4 | $90 |
| ABBVIE INC. | 3 | $89 |
| Teva Pharmaceuticals USA, Inc. | 3 | $74 |
| Vanda Pharmaceuticals Inc. | 2 | $58 |
| Braeburn Inc. | 2 | $58 |
| Supernus Pharmaceuticals, Inc. | 2 | $57 |
Products named: CAPLYTA, ABILIFY MAINTENA, REXULTI, ABILIFY ASIMTUFII, VRAYLAR, ARISTADA, COBENFY, SPRAVATO.
Industry payments across IL — which companies pay providers there.
